Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$20.31 USD
+0.24 (1.20%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $20.35 +0.04 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Liquidia Technologies, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LQDA 20.31 +0.24(1.20%)
Will LQDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LQDA
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Insmed Stock Jumps 29% on Encouraging PAH Study Results
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?
Other News for LQDA
Liquidia Corp (LQDA) Announces Upcoming Second Quarter 2025 Financial Results | LQDA stock news
Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 | LQDA ...
Liquidia (LQDA) Shares Drop Amid Legal Battle with United Therapeutics
United Therapeutics up 7%, Liquidia down 9% in afternoon trading
Bleecker Street Research short United Therapeutics, long Liquidia